Interface Fund — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Motif Neurotechmotifneuro.tech in 𝕏Jan 2024

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)

Co-investorsArboretum Ventures Divergent Capital Dolby Family Ventures Features Capital Holdings PsyMed Ventures TMC Venture Fund +6 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.